Feature Channels:

Cardiovascular Health

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Mount Sinai Health System, Teva Pharmaceuticals, world economic forum, Sustainable Development, Multiple Chronic Conditions, Arnhold Institute for Global Health

New Initiative Creates Scalable Solutions to Improve Care of Patients with Multiple Chronic Conditions

Teva and Mount Sinai Health System pursue new models to reduce cost and complexity of care

Medicine

Channels:

pediatric cardiology, Cardiology, Congenital Heart Disease, single-ventricle disease, Fontan operation, Interventional Cardiology, Cardiac Catheterization

Re-Interventions Are Common in Long-Term Survivors of Childhood Heart Operations

Glatz_AndrewRGB-10.jpg

Among patients who undergo childhood heart surgery for the severe birth defect single-ventricle disease, two-thirds of survivors require a surgical or catheter-based procedure within 20 years. Pediatric cardiology researchers note that doctors should counsel families about the likelihood of re-interventions.

Medicine

Channels:

Temple, Temple University Hospital, Temple Hospital , Philadelphia, North Philadelphia, Grant, Research Grant, Developed

$11.6 Million NIH Grant Supports Temple Researchers’ Exploration of New Cell-Free Stem Cell-Based Possibilities in Heart Repair

The incidence of heart disease is on the rise, and new therapeutic strategies are needed.

Medicine

Channels:

the Mount Sinai Health System, Mount Sinai St. Luke's, Medicaid Patients, Congestive Heart Failure, City Health Works, Harlem

Mount Sinai and City Health Works Partner on New Pilot Program: Medicaid Patients with Congestive Heart Failure Coached at Home on Self-Care

City Health Works and Mount Sinai St. Luke’s (MSSL) are collaborating on a one-year pilot, launched in mid-July, to reduce hospital readmissions for patients with congestive heart failure.

Medicine

Channels:

congential heart defect, Open-heart surgery, Tetralogy of Fallot , Alterra Adaptive Prestent, Evan Zahn

Congenital Heart Disease Expert Implants First-of-Its-Kind Pulmonary Heart Valve Device In an FDA-Approved Clinical Trial

A Cedars-Sinai interventional cardiologist has performed the first minimally invasive procedure using a device that could spare patients with a common congenital heart defect from undergoing multiple open-heart surgeries. B-Roll Video Available

Medicine

Channels:

Afib, AFib treatment, atrial fibrillation (AF), atrial fibrillation treatment, Electrophysiology, Watchman Device, Stroke Prevention

Preventing Strokes in Patients with AFib

dr_Mittal2cropped.jpg

Did you know that more than 3 million Americans are affected by atrial fibrillation? Atrial fibrillation, which is also referred to as AF or AFib, is the most common irregular or abnormal heart rhythm disorder. It decreases the heart’s pumping ability and can make the heart work less efficiently. In addition, patients must be aware that AFib can lead to potentially life-threatening problems such as blood clots and a higher risk of stroke.

Medicine

Channels:

Ribosomes

SLU Researcher Discovers How Hibernating Ribosomes Wake Up

Yap_960.jpg

Saint Louis University scientist Mee-Ngan F. Yap, Ph.D.,has uncovered the way a bacterial ribosome moves from an inactive to an active form, and how that "wake up call" is key to its survival.

Medicine

Channels:

Cardiology, Interventional Cardiology, Medical Research, Clinical Trials, first report investigations, Stents, TAVR, Transcather aortic valve implantation, transcather valve replacement, Coronary Artery Disease, Left Atrial Appendage, transcatheter mitral valve replacement, drug-eluting stents, DAPT, Dual antiplatelet, Dual antiplatelet therapy, bioresorb

Announcing the TCT 2017 Late-Breaking Trials and First Report Investigations

The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place October 29 – November 2, 2017 at the Colorado Convention Center in Denver, Colorado.

Medicine

Channels:

Obesity

Study Shows So-Called ‘Healthy Obesity’ Is Harmful to Cardiovascular Heath

Imageillustratesscientistsresearch.JPG

Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either ‘healthy obese’ or deemed to be ‘normal weight’ but have metabolic abnormalities such as diabetes.

Medicine

Channels:

Kidney Disease, kidney disease research, drug candidates

Vanderbilt, Bayer Collaborate To Develop New Therapies Against Kidney Diseases

Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.







Chat now!